Back

VasCraft: a human decellularized and re-endothelialized tissue-engineered vascular graft for coronary arterial revascularization

11 May 2026 (13:43 - 13:57)
Organised by: Logo
Congress Presentation Part of: Young Investigator Award (YIA) Basic Science Gene Therapy, Cell Therapy HFA Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Miss Georgina Iraola Picornell

IGTP, Badalona, Barcelona (Spain)

3 More presentations in this session

Presentation thumbnail
Phosphoproteomics distinguishes disease-specific mechanisms for human phospholamban cardiomyopathy reversible by RNA therapy
Mr F. Deiman (Groningen, NL)
Abstract Slides Video
Presentation thumbnail
Prognostic value of right ventricular systolic function markers in ATTR-CM
Mr A. Moniz Garcia (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Epigenetic BET protein signaling drives autophagy dysfunction in HFpEF
Doctor L. Di Venanzio (Zurich, CH)
Abstract Slides Video

Access the full session

Session thumbnail
Young Investigator Award (YIA) Basic Science
Video

The Event

Event poster

Heart Failure 2026

11 May 2026 13:43 CET
You may be interested in
thumbnail
Congress Presentation
VasCraft: new decellularized and re-endothelialized human vascular graft produced by tissue engineering for use in arterial bypass
thumbnail
Congress Session
Young Investigator Award (YIA) Basic Science
thumbnail
Congress Presentation
Gene therapy targeting intimal hyperplasia

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources